Ceribell │ AI-Powered Point-of-Care EEG

Ceribell │ AI-Powered Point-of-Care EEG

医疗设备制造业

Sunnyvale,California 13,644 位关注者

Point-of-care EEG for seizure triage and treatment optimization

关于我们

Ceribell, Inc., the developer of the first AI-powered point-of-care EEG diagnostic system, is revolutionizing seizure management in acute care. Ceribell’s mission is to make EEG diagnostics widely available, more efficient, and more cost-effective, to improve the detection and treatment of neurological conditions. The Ceribell system provides rapid access to accurate diagnostic information and continuous monitoring at the bedside 24/7, enabling precise patient care and hospital-wide efficiencies. The Ceribell system first received FDA 510(k) clearance in 2017 and is commercially available in the United States. The latest ClarityPro? AI algorithm is the first and only FDA-indicated software for the diagnosis of Electrographic Status Epilepticus with U.S. Centers for Medicare and Medicaid Services approved New Technology Add-on Payment (NTAP).

网站
https://www.ceribell.com
所属行业
医疗设备制造业
规模
51-200 人
总部
Sunnyvale,California
类型
私人持股
创立
2014
领域
neurodiagnostics、Brain waves、Electroencephalography (EEG)、Epilepsy、Seizures、Coma、Brain monitor、Point-of-care、Healthcare、Technology、disruptive和Rapid EEG

地点

  • 主要

    360 N Pastoria Ave

    US,California,Sunnyvale,94085

    获取路线

Ceribell │ AI-Powered Point-of-Care EEG员工

动态

相似主页

查看职位

融资